By SPC News Staff
Low-intensity blood stem cell transplants (SCTs), which use milder conditioning agents than standard SCTs, may approve lung function in some patients with sickle cell disease (SCD) without damaging the lungs (Ann Am Thorac Soc 2024 Jun 26. https://doi.org/10.1513/AnnalsATS.202309-771OC).
Damage to lung tissue and worsened lung function is a major complication and the leading cause of death in people with SCD. The new study helps determine whether less intensive types of